ANDROGENETIC ALOPECIA
Clinical trials for ANDROGENETIC ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug EPI-001 could help regrow hair in balding adults
Disease control Recruiting nowThis study tests a new drug, EPI-001, for safety and early effectiveness in treating common hair loss (androgenetic alopecia). About 42 adults will take part. The first part finds the best dose, and the second part compares the drug to a placebo over up to 48 weeks.
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: Epibiotech • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
New foam could help women regrow hair – clinical trial underway
Disease control Recruiting nowThis study tests a 5% minoxidil foam (a hair growth treatment) against a placebo in 294 women with female pattern baldness. Participants apply the foam once daily for 24 weeks. The main goal is to see if it increases the number of terminal hairs in a target area on the scalp. The…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New hair lotion aims to thicken thinning hair in men
Disease control Recruiting nowThis study tests a new hair lotion (Finlândia) for men with male pattern baldness. About 190 men aged 18 to 60 who already use minoxidil will use the lotion for 6 months. Researchers will check if it increases hair density and monitor for side effects.
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
Hair loss breakdown: secretome or PRP – which injection wins for thicker hair?
Disease control Recruiting nowThis study tests whether injections of secretome (a substance from stem cells) or platelet-rich plasma (PRP, made from your own blood) can improve hair density and thickness in people with male or female pattern baldness. About 40 adults aged 25–59 will receive one of the two tre…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New pill could help women regrow hair – major trial underway
Disease control Recruiting nowThis study tests an experimental oral drug called VDPHL01 for women with genetic hair loss (androgenetic alopecia). About 552 women aged 18-65 with mild to moderate hair loss will receive either the drug or a placebo for 13 months. The main goal is to see if the drug increases ha…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC
-
New laser shows promise for hair loss – small study underway
Symptom relief Recruiting nowThis study is testing whether a special laser (1470nm) can safely help people with two types of hair loss: male/female pattern baldness and scarring alopecia. Ten adults with stable hair loss will receive the laser treatment and be monitored for changes in hair count and density.…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC
-
Could a simple pill reverse hair loss in women? new trial aims to find out
Symptom relief Recruiting nowThis study tests whether a daily 1mg minoxidil pill works as well as the standard topical foam or solution for women with hormone-related hair loss. About 520 women will be randomly assigned to receive the pill, the topical treatment, or a placebo for up to 36 weeks. Researchers …
Matched conditions: ANDROGENETIC ALOPECIA
Phase: PHASE3 • Sponsor: Industrial Farmacéutica Cantabria, S.A. • Aim: Symptom relief
Last updated Jun 01, 2026 17:58 UTC
-
Scientists probe JAK2's role in male pattern baldness
Knowledge-focused Recruiting nowThis study looks at a protein called JAK2 in the scalps of 25 men with male pattern baldness. Researchers will compare JAK2 levels in balding and non-balding areas, then see if 3 months of minoxidil 5% lotion changes those levels. The goal is to better understand the biology of h…
Matched conditions: ANDROGENETIC ALOPECIA
Phase: NA • Sponsor: Kasr El Aini Hospital • Aim: Knowledge-focused
Last updated Jun 02, 2026 11:59 UTC